Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C G Fanelli

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Diabetes & Metabolism|June 11, 2017
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetesP Lucidi, F Porcellati, A Marinelli Andreoli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2004
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulinF Porcellati, P Rossetti, S Pampanelli, et al.
The Journal of Clinical Investigation|June 1, 1992
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysisC G Fanelli, P De Feo, F Porcellati, et al.
Diabetes|September 3, 1998
Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetesC G Fanelli, C S Dence, J Markham, et al.
Diabetologia|December 13, 2006
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemiaF Porcellati, S Pampanelli, P Rossetti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 8, 2014
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response studyP Lucidi, F Porcellati, P Candeloro, et al.
Diabetes|July 27, 2001
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemiaS A Segel, C G Fanelli, C S Dence, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 2, 2019
Corrigendum to "Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population" [Nutr Metabol Cardiovasc Dis 29 (5) (May 2019) 496-503]R C Bonadonna, A Giaccari, R Buzzetti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 7, 2019
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and populationR C Bonadonna, A Giaccari, R Buzzetti, et al.
Diabetes|November 1, 1993
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDMC G Fanelli, L Epifano, A M Rambotti, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Diabetes & Metabolism|June 11, 2017
Different insulin concentrations in resuspended vs. unsuspended NPH insulin: Practical aspects of subcutaneous injection in patients with diabetesP Lucidi, F Porcellati, A Marinelli Andreoli, et al.
Diabetic Medicine : a Journal of the British Diabetic Association|October 23, 2004
Better long-term glycaemic control with the basal insulin glargine as compared with NPH in patients with Type 1 diabetes mellitus given meal-time lispro insulinF Porcellati, P Rossetti, S Pampanelli, et al.
The Journal of Clinical Investigation|June 1, 1992
Adrenergic mechanisms contribute to the late phase of hypoglycemic glucose counterregulation in humans by stimulating lipolysisC G Fanelli, P De Feo, F Porcellati, et al.
Diabetes|September 3, 1998
Blood-to-brain glucose transport and cerebral glucose metabolism are not reduced in poorly controlled type 1 diabetesC G Fanelli, C S Dence, J Markham, et al.
Diabetologia|December 13, 2006
Effect of the amino acid alanine on glucagon secretion in non-diabetic and type 1 diabetic subjects during hyperinsulinaemic euglycaemia, hypoglycaemia and post-hypoglycaemic hyperglycaemiaF Porcellati, S Pampanelli, P Rossetti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 8, 2014
Glargine metabolism over 24 h following its subcutaneous injection in patients with type 2 diabetes mellitus: a dose-response studyP Lucidi, F Porcellati, P Candeloro, et al.
Diabetes|July 27, 2001
Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemiaS A Segel, C G Fanelli, C S Dence, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|July 2, 2019
Corrigendum to "Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and population" [Nutr Metabol Cardiovasc Dis 29 (5) (May 2019) 496-503]R C Bonadonna, A Giaccari, R Buzzetti, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD|April 7, 2019
Italian Titration Approach Study (ITAS) with insulin glargine 300 U/mL in insulin-naïve type 2 diabetes: Design and populationR C Bonadonna, A Giaccari, R Buzzetti, et al.
Diabetes|November 1, 1993
Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDMC G Fanelli, L Epifano, A M Rambotti, et al.
Pageof 3